ArticleDermatology and therapy2025
Epidemiology of Skin Diseases in Poland: Analysis of Prevalence and Risk Factors: A Cross-Sectional Study.
Article in Dermatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Skin-Brain-Exposome Axis in Stress-Sensitive Dermatoses: A Narrative Review.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAlthough skin diseases are a significant public health concern, epidemiological data for Poland is still lacking. This study aimed to fill this scientific gap by analyzing the prevalence of skin diseases and associated risk factors in the Polish population.
methodsA cross-sectional study was conducted using data from the National Healthy Skin Test (2023), an online questionnaire distributed via the Medonet health platform, involving 27,000 adult Polish internet users. Participants self-reported physician-diagnosed skin conditions. The prevalence of these conditions was assessed, and statistical analysis, including logistic regression, was used to evaluate associations with demographic and socioeconomic factors (age, gender, education level, and urbanization).
resultsThe most prevalent skin conditions were herpes labialis (40.6%), dandruff (37.6%), hair loss (34.8%), and acne (32.7%), with 89.5% of participants reporting at least one condition. Striking gender differences were observed, with psoriasis (odds ratio [OR] = 2.10, 95% confidence interval [CI]: 1.80-2.30) and tinea pedis (OR = 2.10, 95% CI: 1.90-2.30) in men, while women were more prone to rosacea (OR = 0.6, 95% CI: 0.50-0.70) and hair loss (OR = 0.70, 95% CI: 0.60-0.70). Higher education was unexpectedly associated with an increased risk of multiple conditions, including acne (OR = 1.50, 95% CI: 1.40-1.60) and non-melanoma skin cancer (OR = 1.40, 95% CI: 1.20-1.80), but a decreased risk of psoriasis (OR = 0.90, 95% CI: 0.80-1.00). Urban residents of cities with > 500,000 inhabitants showed a significantly higher prevalence of atopic dermatitis/eczema (OR = 1.20, 95% CI: 1.00-1.30) and non-melanoma skin cancer (OR = 2.00, 95% CI: 1.40-2.90) compared with other areas.
conclusionsThis first overview of skin disease epidemiology in Poland reveals significant variations in prevalence based on demographic and socioeconomic factors. These findings have important public health implications, suggesting the need for: (1) gender-specific dermatological education campaigns, (2) age-targeted skin cancer screening programs for those over 65 years, (3) improved access to dermatological care in rural areas, and (4) educational interventions addressing the observed socioeconomic disparities in disease prevalence and detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.